missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Acétate de mégestrol, Mikromol™
Description
acétate de mégestrol
Specifications
Specifications
| Nom chimique ou matériau | Megestrol-17-acetate |
| CAS | 595-33-5 |
| Noms d’analytes ou de composants | Megestrol-17-acetate |
| Conditions d’expédition | Température ambiante |
| Formule moléculaire | C24 H32 O4 |
| Certifications/Conformité | ISO 17025 |
| Synonyme | Medroxyprogesterone Acetate Imp. G (EP), Megestrol Acetate, 6-Methyl-3,20-dioxopregna-4,6-dien-17-yl Acetate, 17-(Acetyloxy)-6-methylpregna-4,6-diene-3,20-dione, 17-Hydroxy-6-methylpregna-4,6-diene-3,20-dione acetate, 17-Acetoxy-6-methylpregna-4,6-diene-3,20-dione, 17alpha-Acetoxy-6-dehydro-6-methylprogesterone, 17alpha-Acetoxy-6-methylpregna-4,6-diene-3,20-dione, 17alpha-Hydroxy-6-methylpregna-4,6-diene-3,20-dione acetate, 5071, 6-Dehydro-6-methyl-17alpha-acetoxyprogesterone, 6-Methyl-17alpha-acetoxy-4,6-pregnadiene-3,20-dione, 6-Methyl-17alpha-hydroxy-Delta6-progesterone acetate, 6-Methyl-6-dehydro-17alpha-acetoxyprogesterone, 6-Methyl-Delta4,6-pregnadien-17alpha-ol-3,20-dione acetate, BDH 1298, DMAP, MGA, Magestin, Maygace, Megace, Megalia, Megeron, Megestat, Megestil, Megestin, Megestrol acetate, Megestryl acetate, NSC 71423, Nia, Niagestin, Ovaban, Ovarid, SC 10363, Medroxyprogesterone Acetate Impurity G |
| Formule InChI | InChI=1S/C24H32O4/c1-14-12-18-19(22(4)9-6-17(27)13-21(14)22)7-10-23(5)20(18)8-11-24(23,15(2)25)28-16(3)26/h12-13,18-20H,6-11H2,1-5H3/t18-,19+,20+,22-,23+,24+/m1/s1 |
| SMILES | CC(=O)O[C@@]1(CC[C@H]2[C@@H]3C=C(C)C4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C)C(=O)C |
| Nom IUPAC | [(8R,9S,10R,13S,14S,17R)-17-acetil-6,10,13-trimetil-3-oxo-2,8,9,11,12,14,15,16-octahidro-1H-ciclopenta[a]fenantren-17-il] acetato |
| Show More |
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?